Cegedim

Healthcare Digitization And AI Analytics Will Expand Market Access

AnalystHighTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

16 Jul 25

AnalystHighTarget's Fair Value

€17.00

38.8% undervalued

28 Aug

€10.40

-17.5%

-1.9%

-17.5%

-1.9%

Edit anytime before Jul 16 9:37 PM. Then post Updates to your followers.

Author's Valuation

€17.0

38.8% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

€17.0

38.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

3.23%

Healthtech revenue growth rate

4.84%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.10%

Calculation

€36.65m

Earnings '28

8.96x

PE Ratio '28

€328.38m

Market Cap '28

€328.38m

Market Cap '28

13.71m

No. shares '28

€23.94

Share Price '28

€23.94 Share Price '28

Discounted to 2025 @ 12.10% p.a.

€17.00

Fair Value '25